SCHEMBL22149167

SCHEMBL22149167

Bc1cn(C)c2ncccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.49
CCNT1 O60563 1/20 0.46
PIM1 P11309 1/20 0.46
CCNA2 P20248 1/20 0.46
CDK2 P24941 1/20 0.46
CDK9 P50750 1/20 0.46
CDK5 Q00535 1/20 0.46
CDK5R1 Q15078 1/20 0.46
KDM4E B2RXH2 2/20 0.42
KDM6B O15054 1/20 0.42
KDM5A P29375 1/20 0.42
KDM4C Q9H3R0 1/20 0.42
GSK3B P49841 3/20 0.41
CDK1 P06493 3/20 0.40
CCNB1 P14635 3/20 0.40
FEN1 P39748 1/20 0.40
MET P08581 1/20 0.40
CCNB2 O95067 1/20 0.40
CCNB3 Q8WWL7 1/20 0.40
BRD4 O60885 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL823082 0.78 DYRK1A (0.50) DYRK1ACCNT1PIM1CCNA2CDK2
SCHEMBL1892910 0.77 DYRK1A (0.49) DYRK1ACCNT1PIM1CCNA2CDK2
SCHEMBL20674192 0.77 DYRK1A (0.49) DYRK1ACCNT1PIM1CCNA2CDK2
SCHEMBL16307577 0.77 DYRK1A (0.49) DYRK1ACCNT1PIM1CCNA2CDK2
SCHEMBL15792325 0.77 DYRK1A (0.49) DYRK1ACCNT1PIM1CCNA2CDK2
SCHEMBL30503547 0.77 DYRK1A (0.49) DYRK1ACCNT1PIM1CCNA2CDK2
SCHEMBL30731192 0.77 DYRK1A (0.49) DYRK1ACCNT1PIM1CCNA2CDK2
SCHEMBL14197833 0.77 DYRK1A (0.49) DYRK1ACCNT1PIM1CCNA2CDK2
SCHEMBL27439703 0.76 DYRK1A (0.59) DYRK1ACCNT1PIM1CCNA2CDK2
SCHEMBL23104761 0.74 DYRK1A (0.47) DYRK1ACCNT1PIM1CCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020125673-A1 INFLUENZA VIRUS REPLICATION INHIBITOR, INTERMEDIATE AND USE THEREOF 南京药石科技股份有限公司 2020-06-25 WO disclosed